Although accumulating evidence showed that a large number of genetic factors, such as HLA-B51, IL-23R, miR-146a, miR-182, IL12B, DHCR7, FAS, ERAP1, and ATG5, are involved in the susceptibility to BD, [4] [5] [6] [7] [8] [9] [10] [11] [12] the exact etiology of BD remains unclear. Recently, genome-wide association studies (GWAS) in a Japanese cohort identified 2 suggestive associations on chromosome 1p31.3 (rs12119179 in IL23R-IL12RB2) and 1q32.1 (rs1554286 in IL10). 13 Two other loci (rs1495965 in IL23R-IL12RB2 and rs1800871 in IL10) have also been found to be significantly associated with BD after meta-analyzing the former 2 loci with results from additional Turkish and Korean cohorts. 13 In addition, a GWAS in a Turkish cohort has confirmed the known association of BD with HLA-B51 and identified a new susceptibility locus (rs1518111 in IL10) with BD.
14 Besides this, another GWAS has identified new susceptibility loci for BD and epistasis between HLA-B51 and ERAP1. 15 Furthermore, a GWAS in a Chinese BD cohort performed by our group identified rs897200 around STAT4 as a novel locus for this disease. 16 It is obvious that the genetic background of BD may vary between different ethnic populations. A stringent P value below 5.0 3 10 28 is generally considered as the threshold for genome-wide significance, but may miss loci showing weaker associations that are also involved in the development of BD and there is therefore a need to further investigate these loci in various ethnic groups.
Hence, with the aim of investigating the possible role of the socalled GWAS-identified nearly positive associations (5.0 3 10 28 < P < 1.0 3 10
25
), we conducted a GWAS replication study in a Chinese Han population. Our results not only confirmed the association of IL10/rs1800871 and IL23R-IL12RB2/rs924080 with BD but also identified 2 susceptibility single nucleotide polymorphisms (SNPs) in IL10 and IL23R-IL12RB2 (rs3024490 and rs12141431). 17 All patients with BD enrolled in this study had uveitis. In parallel, a total of 2475 healthy individuals representing the same ethnical population and geographic area with the patients with BD were enrolled in this study to serve as the controls. These controls were matched for sex and age with the patients with BD. The study was conducted in accordance with the tenets of the Declaration of Helsinki and received approval from the Ethics Research Committee at the Chongqing Medical University (permit no. . Before blood collection, all patients and controls were informed of this study and provided their written informed consent.
METHODS

Case-control cohorts
SNP selection and genotyping
Based on the potential susceptibility loci with a P value between 5.0 3 10 28 and 1.0 3 10 25 as identified in previous GWAS results, [13] [14] [15] [16] 31 candidate SNPs (27 SNPs were in or near 22 genes, whereas 4 SNPs were in intergenic regions) were selected in this study (see Table I ). Because the SNPs rs11209033 and rs12141431 were reported to be in strong linkage disequilibrium (LD) with each other, 13 we used only rs12141431 in our study. Similarly, SNPs rs1800871 and rs1554286 were also identified to be in a strong LD with each other, 18 and therefore only rs1800871 was used. Besides, no polymorphic data of the 3 SNPs (rs9819066, rs6549400, and rs11706279) were available in the Chinese Han database of single nucleotide polymorphism, and therefore we excluded them from this study. Genotyping analysis of the SNPs selected for validation was performed using iPLEX Gold Genotyping Assay and Sequenom MassArray (Sequenom, San Diego, Calif). Locus-specific PCR and detection primers were designed using the MassArray Assay Design 3.1 software (Sequenom) (see Table E1 in this article's Online Repository at www.jacionline.org). The complete experiment was carried out in strict accordance with standard procedures. For all SNPs, we examined the clustering patterns of genotypes and selected mass peaks and confirmed that the genotype calls were of good quality.
Cell isolation and culture
Ficoll-Hypaque density-gradient centrifugation was used to obtain PBMCs from venous blood of healthy controls. PBMCs were counted by microscope and then seeded into 24-well culture plates (1 3 10 6 cells per well). The cells were cultured in culture medium consisting of RPMI medium 1640, 10% FCS (Greiner, Wemmel, Belgium), 100 U/mL penicillin, and 100 mg/mL streptomycin. To investigate the effect of gene polymorphisms on the expression of IL23R, IL12RB2, and IL10, PBMCs were cultured with or without anti-CD3/ CD28 antibodies (5:1) (Miltenyi Biotec, Palo Alto, Calif) at 378C for 72 hours. 
Real-time PCR
Total RNA was extracted from unstimulated PBMCs and anti-CD3/CD28 antibodies-stimulated PBMCs using TRIzol Reagent (Invitrogen, Carlsbad, Calif), and the reverse transcription was performed using a transcriptase kit (Applied Biosysterms, ABI, Foster City, Calif). Real-time PCR was carried out using the Applied Biosystems 7500 System based on the SYBR-Green method. The expression of IL23R, IL12RB2, IL10, and b-actin (the internal reference) was detected using the primers as described in earlier studies (see Table E2 in this article's Online Repository at www.jacionline. org). [19] [20] [21] All tests were conducted in triplicate, and the relative expression levels of the candidate genes were quantified by using the 2 2DDCt method.
Measurement of cytokines by ELISA
Supernatants of anti-CD3/CD28 antibodies-stimulated PBMCs were collected and stored at 2808C until laboratory testing. The production of IFNg, IL-10, and IL-17 was quantified using Duoset ELISA development kits (R&D Systems, Minneapolis, Minn) in accordance with the manufacturer instructions.
Statistical analysis
Hardy-Weinberg equilibrium was analyzed by the x 2 test. Genotype and allele frequencies of candidate SNPs were compared between patients with BD and healthy controls by the x 2 test using SPSS version 17.0 (SPSS, Inc, Chicago, Ill), which was also applied to calculate odds ratios (ORs) and 95% CI. For multiple comparisons, Bonferroni correction was applied in this study, and a P value of less than 4.90 3 10 24 (0.05/102) was considered to be statistically significant. The nonparametric Mann-Whitney U test or independent samples t test was used to compare IL23R, IL12RB2, and IL10 expression levels as well as cytokine levels among different genotype groups.
RESULTS
Clinical manifestations of the enrolled patients with BD
The detailed demographic characteristics and clinical manifestations of patients with BD enrolled in this study are presented in Table II . The distribution of clinical symptoms in the patients with BD is as follows: 100% with oral ulcer, 51.1% with genital ulcer, 72.1% with skin lesions, 18.5% with arthritis, and 21.4% with a positive pathergy test.
Allele and genotype frequencies of tested SNPs in patients and controls in the study Twenty-six SNPs (23 SNPs were in or near 22 genes, whereas 3 SNPs were in intergenic regions) were genotyped in 1206 patients with BD and 2475 healthy controls. Our results showed significantly increased frequencies of the IL23R-IL12RB2/rs924080 TT genotype (P 5 2.03 3 10
28
; OR 5 1.50) and the IL23R-IL12RB2/rs12141431 CC genotype (P 5 2.18 3 10
; OR 5 1.53) in BD (see Table III ). In addition, the frequencies of the TT genotype for IL10/rs1800871 and the TT genotype for IL10/rs3024490 showed a significant increase in patients with BD (P 5 5.88 3 10
; OR 5 1.47; P 5 2.80 3 10
25
; OR 5 1.34) (see Table III ). No significant differences in the other 22 investigated SNPs were detected between patients with BD and healthy individuals (see Table E3 in this article's Online Repository at www.jacionline.org).
Stratified analysis for rs924080, rs12141431, rs1800871, and rs3024490 with main clinical features of BD A stratified analysis was performed to examine the association of rs924080, rs12141431, rs1800871, and rs3024490 with the main clinical features of BD. The main clinical manifestations of BD included genital ulcer, skin lesions, arthritis, and positive pathergy reaction. We could not demonstrate a significant association of the rs924080, rs12141431, rs1800871, and rs3024490 genotype frequency with any clinical manifestation of BD (see Tables E4-E7 in this article's Online Repository at www.jacionline.org).
The influence of rs924080 and rs12141431 on the expression of IL23R and IL12RB2
The aforementioned result revealed significant associations of SNPs rs924080 and rs12141431 of IL23R-IL12RB2 with BD. To investigate a possible function associated with these SNPs, we conducted real-time PCR experiments to evaluate their effect on the mRNA expression of IL23R and IL12RB2 using PBMCs isolated from healthy individuals with a known genotype. The results did not show a significant effect of the various genotypes of SNPs rs12141431 and rs924080 on the expression of IL23R and IL12RB2 (see Fig 1, A; Fig E1, A, to Fig E3, B ; P > .05). We subsequently examined whether the expression of IL23R and IL12RB2 was affected by the various genotypes of rs12141431 and rs924080 when PBMCs were stimulated with a cocktail of anti-CD3/CD28 antibodies to simulate antigen presentation. Stimulation caused a significantly increased expression of IL23R in rs12141431/CC carriers compared with rs12141431/ GG carriers (see Fig 1, B ; P 5 .002). However, no significant effect of IL23R and IL12RB2 on mRNA expression was observed for rs924080 among different genotypes in PBMCs stimulated with anti-CD3/CD28 antibodies (see Fig E1, A, to Fig E3, B ; P > .05).
The influence of rs1800871 and rs3024490 on the expression of IL10
As the results suggested that 2 SNPs of IL10 were associated with BD, we carried out a real-time PCR analysis to explore whether IL10 mRNA expression was affected by the different genotypes of rs1800871 and rs3024490. The results showed that no significant associations were observed between IL10 mRNA expression and the various genotypes of rs3024490 or rs1800871 in unstimulated PBMCs (see The influence of rs12141431 and rs3024490 on cytokine production
As the aforementioned results revealed that different genotypes of rs12141431 or rs3024490 affected the expression of IL23R or IL10, we performed a further study to explore whether the various genotypes of these 2 SNPs could affect cytokine (IFN-g, IL-10, and IL-17) production in PBMCs treated with anti-CD3/CD28 antibodies. The results showed that the IL-17 production in IL23R-IL12RB2/rs12141431 CC genotype (320 6 78 pg/mL) carriers was significantly increased compared with the carriers with the GG genotype (206.99 6 58.58 pg/mL) (see Fig 3; P 5 .001). Furthermore, IL10/rs3024490 TT genotype carriers (609 6 231 pg/mL) showed a decreased production of IL-10 compared with CC genotype carriers (928 6 244 pg/mL) (see Fig 4; P 5 .005). No significant effect of genotype on IFN-g and IL-10 was found when analyzing the various IL23R-IL12RB2/rs12141431 genotypes (see Figs E5 and E6 in this article's Online Repository at www.jacionline.org; P >.05). Similarly, no significant association of various IL10/rs3024490 genotypes with IFN-g and IL-17 production was observed (see Figs E7 and E8 in this article's Online Repository at www.jacionline.org; P > .05).
DISCUSSION
In the present replication study, we investigated the association between 26 candidate SNPs with a P value between 5.0 3 10 Because of LD or no polymorphic data in Han Chinese, 5 SNPs (rs11209033, rs1554286, rs9819066, rs6549400, and rs11706279) were excluded from this study.
J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 2 in a Chinese Han population. Our results showed that 2 SNPs (rs1800871 and rs3024490) in IL10 and 2 SNPs (rs924080 and rs12141431) in IL23R-IL12RB2 contribute to the genetic susceptibility to BD in Han Chinese. IL10 was 1 of the first 2 identified BD susceptibility loci with genome-wide significance (P < 5.0 3 10
28
) outside the MHCrelated genes from 2 GWAS in Turkish and Japanese populations. Remmers et al 14 demonstrated an association of IL10/rs1518111, which is an intronic variant, with BD in a Turkish population. Mizuki et al 13 found an association of rs1800871 and rs1800872, which were located in the promoter region of IL10, with BD in a Japanese population. The SNP rs1518111 was replicated in Middle Eastern Arab, Greek, British, and Korean samples, and rs1800871 and rs1800872 were replicated in Turkish and Korean patients. 13, 14 Later studies confirmed the association of rs1518111 and rs1800871 with BD in Han Chinese. 18, 22 Another group also confirmed the association of rs1518111 with BD in Iran. 23 In the present study, we confirmed the association of rs1800871 with BD after comparison of 1206 patients with BD and 2475 healthy controls in Han Chinese. Furthermore, our study identified IL10/rs3024490 as a susceptibility SNP underlying BD in Han Chinese. This SNP is located in the intron 1 region of the IL10 gene, which has been identified to confer susceptibility to various diseases, such as cervical cancer and chronic hepatitis B virus infection. 24, 25 The susceptibility SNP IL10/ rs3024490 is in very strong LD with previously reported loci, rs1518111 and rs1800872 (r 2 5 0.94; see Fig E9 in this article's Online Repository at www.jacionline.org), which have been reported to be associated with BD in a previous GWAS in Turkish and Japanese cohorts. 13, 14 P value with Bonferroni correction of less than 4.90 3 10 24 was considered to be significant (shown in boldface).
OR, Odds ratio.
FIG 1.
The influence of various rs12141431 genotypes on the mRNA expression of IL23R. A, Expression of IL23R in nonstimulated PBMCs from normal controls carrying various genotypes of rs12141431 (n 5 11 for the CC genotype, n 5 11 for the CG genotype, and n 5 11 for the GG genotype). B, Expression of IL23R in anti-CD3/CD28 antibodies-stimulated PBMCs from healthy controls carrying various genotypes of rs12141431 (n 5 11 for the CC genotype, n 5 11 for the CG genotype, and n 5 11 for the GG genotype). Real-time PCR was conducted to detect gene expression, and the relative expression levels of IL23R gene were quantified by using the 2 2DDCt method.
The IL23R-IL12RB2 locus was the second non-MHC locus with genome-wide significance identified by 2 early GWAS reports on BD. Mizuki et al 13 identified the association of rs12119179 and rs1495965, which are located in the intergenic region between IL23R and IL12RB2, with BD in a Japanese GWAS. In the Turkish GWAS, Remmers et al 14 identified a suggestive association with rs924080, located similarly in the intergenic region between IL23R and IL12RB2, and obtained genome-wide significance after a meta-analysis with the Japanese samples. However, these variants in the IL23R-IL12RB2 locus were not replicated in smaller Korean, Middle Eastern Arab, Greek, and British cohorts. A later study confirmed the rs924080 association in Iranian patients. 23 In this study, we confirmed the association of rs924080 with BD in a Chinese Han population. Moreover, we identified another SNP rs12141431 to be associated with BD in Han Chinese. To our knowledge, this is the first study to show that rs12141431 in the IL23R-IL12RB2 confers risk to BD in Han Chinese. This SNP is situated in the intergenic region between IL23R and IL12RB2, and up to now, there was no significant association of this locus with other immune-mediated diseases. The susceptibility SNP IL23R-IL12RB2/rs12141431 identified in our study is in very strong LD with the previously reported loci, rs12119179 and rs1495965 (r 2 5 .90; see Fig E10 in this article's Online Repository at www.jacionline.org). These loci were reported to be associated with BD in a previous GWAS in Turkish and Japanese cohorts. 13, 14 We performed functional assays to investigate whether SNPs of the candidate genes influenced gene expression and showed a significantly increased expression of IL23R in rs12141431/CC carriers compared with rs12141431/GG carriers in anti-CD3/ CD28 antibodies-stimulated PBMCs. These data suggest that the intergenic disease-associated common noncoding variants might be associated with increased expression and signaling of IL23R. Similar results were reported in ankylosing spondylitis, 26 psoriasis, 27 and ulcerative colitis. 28 In addition, individuals with the rs3024490/TT genotype were observed to have a significantly decreased IL10 mRNA expression as compared with carriers of the GG genotype in the PBMCs stimulated with anti-CD3/ CD28 antibodies, which was similar to earlier findings reported for IL10/rs1518111.
14 Our gene expression analysis was performed in healthy individuals because the patients with BD in our clinic often present with varying degrees of inflammation and are treated with immunosuppressive drugs, which may alter the response of the lymphocytes. Moreover, our result suggested that IL23R-IL12RB2/rs12141431 CC genotype carriers showed an increased production of IL-17, whereas IL10/rs3024490 TT genotype carriers had a decreased production of IL-10. IL-17 is a proinflammatory cytokine mainly produced by T H 17 cells, 5 11) . B, Expression of IL10 in anti-CD3/CD28 antibodies-stimulated PBMCs from healthy controls carrying various genotypes of rs3024490 (GG 5 11, GT 5 11, TT 5 11). Real-time PCR was performed to detect gene expression, and the relative expression levels of IL10 gene were quantified by using the 2 2DDCt method.
FIG 3.
The influence of various rs12141431 genotypes on IL-17 production (n 5 11 for the CC genotype, n 5 11 for the CG genotype, and n 5 11 for the GG genotype). The production of IL-17 was quantified by ELISA in PBMCs, which were obtained from healthy controls with various rs12141431 genotypes and treated with anti-CD3/CD28 antibodies.
FIG 4.
The influence of various rs3024490 genotypes on IL-10 production (n 5 11 for the GG genotype, n 5 11 for the GT genotype, and n 5 11 for the TT genotype). The production of IL-10 was measured by ELISA in PBMCs, which were obtained from healthy controls carrying various genotypes of rs3024490 and treated with anti-CD3/CD28 antibodies.
and elevated IL-17 expression has been identified to be positively associated with BD activity. [29] [30] [31] Previous studies have shown that IL10 gene encoded IL-10, suppresses the production of proinflammatory cytokines such as IL-1, IL-6, IL-12, TNF, and IFN-g, and inhibits the costimulatory activity of macrophages for T-cell and natural killer-cell activation. 32, 33 Recent studies reported that the IL-10 serum level in patients with BD was significantly lower as compared with healthy controls. 34 It should be noted that IL-23R has been generally accepted to be expressed by activated T cells and not by naive T cells, 35, 36 whereas a recent study also suggested that IL-23R may be expressed by other cell populations present in PBMCs. 37 Further studies are needed to investigate whether polymorphisms of rs12141431 can influence the expression of the IL-23R gene in enriched/sorted T cells.
Our study has several limitations. It should be noted that the associations found were associated with common variants and that the associations have an OR of approximately 1.5. Nevertheless, it adds to the existing knowledge concerning the role of IL-23 and IL-10 in the pathogenesis of BD and may be instrumental in developing future treatments of this disease. Because the patients in this survey were recruited from ophthalmic centers, a selection bias for ocular BD may be present. Stratification of our patients according to their clinical manifestations did not reveal any significant associations however. Further confirmation of our findings is needed by examining patients with BD recruited by other clinical disciplines. Furthermore, only those SNPs that had a P value between 5.0 3 10 28 and 1.0 3 10 25 identified in previous GWAS analysis were tested in our study, and it is possible that other SNPs of the investigated genes in this survey might be involved in susceptibility to BD.
Conclusions
This study not only confirms the association of IL10/rs1800871 and IL23R-IL12RB2/rs924080 with BD but also identifies 2 susceptibility SNPs in IL10 and IL23R-IL12RB2 (rs3024490 and rs12141431) with BD in Han Chinese, which may provide future targets for its treatment.
